Agrima Bhatt, Rajasthan University Oncological sciences have moved far in terms of research and development, leading to many novel therapies currently in use. Despite research on tumors and their causes, cancer remains the leading cause of death worldwide. The most popular approach to cancer treatment has been chemotherapy and radiation therapy. These approaches are not […]
Kanikah Mehndiratta, M.Sc., University of Glasgow Vitamin C, also called ascorbic acid, was the first vitamin to be artificially synthesized. It is one of the most essential micronutrients that plays a role in tissue repair and enzymatically producing many neurotransmitters. It is widely used to prevent diseases such as Scurvy. It has antioxidant properties and […]
Soumya Shraddhya Paul, Amity University, Noida Lung cancer is one of the leading causes of cancer-associated deaths in the world. According to WHO, around 1.8 million people all around the world succumbed to lung cancer. With the initial onset of tumor progression, metastasis is the cause of 70% of the mortalities. Due to this reason, […]
Aqsa, Jamia Millia Islamia Cancer is a disease in which cells of the body grow abnormally and uncontrollably. Until now, there is still no permanent cure for cancer, but getting treatment for cancer might allow you to live for a certain period. Research for the cure of cancer has been underway for about 100 years […]
Agrima Bhatt, Rajasthan University Drugs identifying cancer genes: To understand drug-target interaction, let’s first cover our bases to know what is meant by receptor and a ligand. Receptors are defined as the macromolecules present either on the cell surface or in the cytoplasm which is involved in the cell interaction through signalling. Molecules like drugs, […]
Srishti Deb, Amity University, Kolkata Nanoparticle: Technobiology’s wireless messenger – With the advancement of science and modern technologies, a more promising technology of drug delivery to selective tissues is used. This is a more potent targeted delivery process of therapeutic agents, that significantly eliminates drug or drug carrier side effects. Drug design and drug delivery […]
Chitra Roy, University of Calcutta In 1965, a group of British oncologists viewed DNA fragments which were floating around chromosomes in cancer cells. For decades, there has been largely ignored as cellular debris. Recent advancements of technology in the field of genetics and cellular biology has paved a way for better understanding of complex diseases […]
Chitra Roy, University of Calcutta High-Grade Serous Ovarian Carcinoma (HGSOC) is one of the most common and deadliest types of ovarian cancer. This gynaecological malignancy is a type of tumour which arises from the ovary, fallopian tube, or peritoneum. The tumour microenvironment is very complex and 40% of this tumour mass contains Macrophages. Macrophages originate […]
RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA BET (Bromodomain and extra terminal domain) proteins are described to be epigenetic and anti-cancer drug targets. This was the first-in-human study that judged the pharmacokinetics and prior activity of ODM-20, the inhibitor of BET in patients having solid tumours. The main objective was to determine the tolerability, dose-limiting toxicities (DLT), […]
